AIMC Topic: CD163 Antigen

Clear Filters Showing 1 to 2 of 2 articles

Artificial intelligence-based virtual staining platform for identifying tumor-associated macrophages from hematoxylin and eosin-stained images.

European journal of cancer (Oxford, England : 1990) Mar 26, 2025
BACKGROUND: Virtual staining is an artificial intelligence-based approach that transforms pathology images between stain types, such as hematoxylin and eosin (H&E) to immunohistochemistry (IHC), providing a tissue-preserving and efficient alternative...
Humans Artificial Intelligence Female Tumor Microenvironment Male Staining and Labeling Squamous Cell Carcinoma of Head and Neck Immunohistochemistry Tumor-Associated Macrophages Oropharyngeal Neoplasms Eosine Yellowish-(YS) Hematoxylin Antigens, Differentiation, Myelomonocytic CD163 Antigen
View on PubMed DOI

MIA and CD163 as promising diagnostic biomarkers in vascular dementia: A multi-method study combining WGCNA, machine learning with validation in animal models and clinical samples.

International immunopharmacology Sep 23, 2025
Vascular dementia (VaD), the second most common form of dementia, lacks reliable biomarkers for early diagnosis. Here, we integrated weighted gene co-expression network analysis (WGCNA) with machine learning to identify novel biomarkers and immune-me...
Humans Machine Learning Macrophages Biomarkers Female Aged Animals Male Gene Regulatory Networks Rats Disease Models, Animal Antigens, CD Receptors, Cell Surface Dementia, Vascular Antigens, Differentiation, Myelomonocytic CD163 Antigen
View on PubMed DOI
Popular Topics
Recent Journals